These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 12478546)
1. Targeting epidermal growth factor receptor in head and neck cancer. Ford AC; Grandis JR Head Neck; 2003 Jan; 25(1):67-73. PubMed ID: 12478546 [TBL] [Abstract][Full Text] [Related]
2. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity. Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466 [TBL] [Abstract][Full Text] [Related]
3. Rational bases for the development of EGFR inhibitors for cancer treatment. Bianco R; Gelardi T; Damiano V; Ciardiello F; Tortora G Int J Biochem Cell Biol; 2007; 39(7-8):1416-31. PubMed ID: 17596994 [TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy. Ang KK; Andratschke NH; Milas L Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):959-65. PubMed ID: 14967456 [TBL] [Abstract][Full Text] [Related]
5. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting. Sok JC; Coppelli FM; Thomas SM; Lango MN; Xi S; Hunt JL; Freilino ML; Graner MW; Wikstrand CJ; Bigner DD; Gooding WE; Furnari FB; Grandis JR Clin Cancer Res; 2006 Sep; 12(17):5064-73. PubMed ID: 16951222 [TBL] [Abstract][Full Text] [Related]
7. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells. Zhang Q; Thomas SM; Xi S; Smithgall TE; Siegfried JM; Kamens J; Gooding WE; Grandis JR Cancer Res; 2004 Sep; 64(17):6166-73. PubMed ID: 15342401 [TBL] [Abstract][Full Text] [Related]
8. Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma. Thomas SM; Bhola NE; Zhang Q; Contrucci SC; Wentzel AL; Freilino ML; Gooding WE; Siegfried JM; Chan DC; Grandis JR Cancer Res; 2006 Dec; 66(24):11831-9. PubMed ID: 17178880 [TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor biology in head and neck cancer. Kalyankrishna S; Grandis JR J Clin Oncol; 2006 Jun; 24(17):2666-72. PubMed ID: 16763281 [TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma. Thomas SM; Coppelli FM; Wells A; Gooding WE; Song J; Kassis J; Drenning SD; Grandis JR Cancer Res; 2003 Sep; 63(17):5629-35. PubMed ID: 14500405 [TBL] [Abstract][Full Text] [Related]
11. Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer. Astsaturov I; Cohen RB; Harari P Expert Rev Anticancer Ther; 2006 Sep; 6(9):1179-93. PubMed ID: 17020453 [TBL] [Abstract][Full Text] [Related]
12. Targeting epidermal growth factor receptor signaling: early results and future trends in oncology. Lage A; Crombet T; González G Ann Med; 2003; 35(5):327-36. PubMed ID: 12952019 [TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer. Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559 [TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor: a promising target in solid tumours. Laskin JJ; Sandler AB Cancer Treat Rev; 2004 Feb; 30(1):1-17. PubMed ID: 14766123 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-1 receptor and ligand targeting in head and neck squamous cell carcinoma. Slomiany MG; Black LA; Kibbey MM; Tingler MA; Day TA; Rosenzweig SA Cancer Lett; 2007 Apr; 248(2):269-79. PubMed ID: 16996205 [TBL] [Abstract][Full Text] [Related]
16. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer. Wang SJ; Bourguignon LY Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):771-8. PubMed ID: 16847188 [TBL] [Abstract][Full Text] [Related]